APTA - Ticker AI Digest

Aptamer Group PLC 📰 1
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Aptamer Group PLC in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
APTA Data 2025-08-05 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (APTA) 1
APTA 07:06
Aptamer Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 3
APTA 07:06
Aptamer Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
APTA 11:26
Aptamer Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
APTA 13:54
Aptamer Group PLC
Holding(s) in Company
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
APTA 06:01
Aptamer Group PLC
Trading Update
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Aptamer Group PLC (AIMAPTA) released a trading update for the year ended 30 June 2025, highlighting robust revenue growth and a strengthened financial position. The company reported unaudited revenue of £1.20 million, a 41% increase from the previous year, and a year-end cash position of £1.06 million, further bolstered by a successful £1.83 million fundraise.
Key achievements include
1. **Partnerships and Licensing Agreements**: Aptamer signed two new licensing agreements with Neuro-Bio and the University of Glasgow, and advanced multiple deals with global enzyme suppliers, synthetic biology companies, and a global health organization. Repeat engagements with blue-chip clients like Unilever and top pharmaceutical companies underscore the platforms value.
2. **Technical Advancements**Significant progress was made in converting Neuro-Bio Alzheimers binders to ELISA format, evaluating prenatal diagnosis Optimers with a global life science leader, and developing an Optimer-based delivery vehicle for liver fibrosis. These advancements create a clear pathway to commercialization.
3. **Strategic Positioning**With a strengthened balance sheet and investor confidence, Aptamer is well-positioned to advance its pipeline, generate licensing revenues, and deliver long-term shareholder value. CEO Dr. Arron Tolley emphasized the companys transition from innovation to high-value commercial partnerships and repeat business from industry leaders.
Aptamer Group continues to focus on building long-term licensing revenues and expanding its Optimer® platform across diverse applications in medicine, diagnostics, and research.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and cash position comparisons.
MetricFinancial Year Ended 30 June 2024Financial Year Ended 30 June 2025Year-on-Year Change
Revenue (£ million)0.851.20+41%
Cash Position at Year-End (£ million)Not Provided1.06N/A
Post-Period Fundraise (£ million, net)Not Provided1.83N/A
DebtNot ProvidedNot ProvidedN/A
### Explanation: 1. **Revenue**: The table compares the revenue for the financial years ended 30 June 2024 (£0.85 million) and 30 June 2025 (£1.20 million), showing a 41% increase. 2. **Cash Position**: Only the 2025 figure (£1.06 million) is provided, so the year-on-year change is marked as "N/A". 3. **Post-Period Fundraise**: The 2025 fundraise (£1.83 million) is included for context, as it strengthens the balance sheet. 4. **Debt**: No debt figures are mentioned in the text, so all fields are marked as "Not Provided". This table provides a clear comparison of the available financial metrics year-on-year.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 9
APTA 07:06
Aptamer Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
APTA 12:30
Aptamer Group PLC
Investor Webinar
APTA 06:01
Aptamer Group PLC
Trading Update
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Aptamer Group PLC (AIMAPTA) released a trading update for the year ended 30 June 2025, highlighting robust revenue growth and a strengthened financial position. The company reported unaudited revenue of £1.20 million, a 41% increase from the previous year, and a year-end cash position of £1.06 million, further bolstered by a successful £1.83 million fundraise.
Key achievements include
1. **Partnerships and Licensing Agreements**: Aptamer signed two new licensing agreements with Neuro-Bio and the University of Glasgow, and advanced multiple deals with global enzyme suppliers, synthetic biology companies, and a global health organization. Repeat engagements with blue-chip clients like Unilever and top pharmaceutical companies underscore the platforms value.
2. **Technical Advancements**Significant progress was made in converting Neuro-Bio Alzheimers binders to ELISA format, evaluating prenatal diagnosis Optimers with a global life science leader, and developing an Optimer-based delivery vehicle for liver fibrosis. These advancements create a clear pathway to commercialization.
3. **Strategic Positioning**With a strengthened balance sheet and investor confidence, Aptamer is well-positioned to advance its pipeline, generate licensing revenues, and deliver long-term shareholder value. CEO Dr. Arron Tolley emphasized the companys transition from innovation to high-value commercial partnerships and repeat business from industry leaders.
Aptamer Group continues to focus on building long-term licensing revenues and expanding its Optimer® platform across diverse applications in medicine, diagnostics, and research.
Below is the HTML table code comparing the financials and debt year-on-year based on the provided text. Since the text does not explicitly mention debt figures, the table focuses on revenue and cash position comparisons.
MetricFinancial Year Ended 30 June 2024Financial Year Ended 30 June 2025Year-on-Year Change
Revenue (£ million)0.851.20+41%
Cash Position at Year-End (£ million)Not Provided1.06N/A
Post-Period Fundraise (£ million, net)Not Provided1.83N/A
DebtNot ProvidedNot ProvidedN/A
### Explanation: 1. **Revenue**: The table compares the revenue for the financial years ended 30 June 2024 (£0.85 million) and 30 June 2025 (£1.20 million), showing a 41% increase. 2. **Cash Position**: Only the 2025 figure (£1.06 million) is provided, so the year-on-year change is marked as "N/A". 3. **Post-Period Fundraise**: The 2025 fundraise (£1.83 million) is included for context, as it strengthens the balance sheet. 4. **Debt**: No debt figures are mentioned in the text, so all fields are marked as "Not Provided". This table provides a clear comparison of the available financial metrics year-on-year.
APTA 11:26
Aptamer Group PLC
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
APTA 10:49
Aptamer Group PLC
Result of General Meeting
APTA 06:01
Aptamer Group PLC
Additional work commissioned by Unilever
APTA 06:01
Aptamer Group PLC
Issue of Equity in lieu of Non-Exec Director Fees
APTA 13:54
Aptamer Group PLC
Holding(s) in Company
APTA 06:01
Aptamer Group PLC
Posting of Circular and Notice of General Meeting

Today's AI

Today's AI Starts With News

1 live catalyst is opening Today’s AI for APTA.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2025-08-05 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Aptamer Group PLC has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
APTA signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Aptamer Group PLC. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full APTA Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for APTA on 2025-08-05.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
18.9M
Enterprise Value
43.3M
Public Float
66.7
Broker Target
180
Shares Out
3.2B
Long Interest
100
Short Interest
0
Exchange
LSE
Currency Code
GBX
ISIN
GB00BNRRP542
Market
None
Sector
Health Care
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for APTA.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2025-08-05 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Aptamer Group PLC has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-03-09
Net Debt
-568.0K
Cash
1.1M
EPS
-
Net Income
-2.4M
Revenue
1.2M
Enterprise Value
43.3M
Trailing PE
-
Forward PE
-
Price Sales TTM
13.7466
Price Book MRQ
7.7951
EV Revenue
11.8776
EV EBITDA
-5.0596
Financial Forecastist

Mixed financial engine

Revenue is accelerating +177.9% against the prior comparable period. Net margin is expanding by 467.7 pts. Net debt is building +70.7%.

Revenue +177.9% Net Income -36.5% FCF -29.7% Current Ratio 2.04x Forward Rev 0
Mixed
Quarter Revenue
828.0K
+177.9%
vs prior comparable quarter
Net Margin
-138.6%
+467.7 pts
profitability pulse
Free Cash Flow
-1.2M
-29.7%
cash conversion
Net Debt / EBITDA
1.0x
+70.7%
lower is cleaner
Revenue Engine

Latest quarter printed 828.0K with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at -1.1M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 1.5M while net debt is -1.2M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2025
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2025
Consensus
17.6M
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
0
Revenue Path
-
EPS / Earnings
Growth cue -

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 828.0K -1.1M -1.2M -1.2M
Q2 2025 550.0K -1.3M -686.0K -568.0K
Q4 2024 653.0K -1.1M -1.3M -1.3M
Q2 2024 562.0K -1.2M -574.0K -53.0K
Q4 2023 298.0K -1.8M -1.8M -700.0K
Q3 2023 149.0K -903.5K -881.5K -1.0M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 1.2M -2.4M -2.3M -2.0M
FY 2024 860.0K -3.0M -2.8M -2.4M
FY 2023 1.8M -7.8M -7.4M -6.1M
FY 2022 4.0M -2.1M -2.2M -2.8M
FY 2021 1.3M -1.8M -2.2M -1.3M

Structure DNA

Market Structure DNA has not been loaded for this ticker yet. Once the A15 loader runs, this desk will light up with regime labels, ownership lock, dividend cadence, and structure charts.

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.5526
Institutions As Of
2025-08-07
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
2
Sale Director Dealing
0
Purchase TR1
4
Sale TR1
2
Broker Coverage Rows
0
Institution Holders Tracked
4
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for APTA, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2025-08-05 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Aptamer Group PLC has fresh news flow live now, so the tape is framing the chart workspace below.
AI Charts Studio
APTA Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-08-05 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 73.08%
RSI Gauge
Price Change
AI Forecast